Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Howard Marks, latest 13F

Coherus BioSciences

In Howard Marks's portfolio · Oaktree Capital Management

Ticker CHRS.CV

Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q2 2025 Sell 0  
Q1 2025 No change 49,030,000 0.9% $48.3M
Q4 2024 Add 7% 49,030,000 0.8% $47.7M
Q3 2024 Add 1215% 46,030,000 0.6% $36.1M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.